- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Tianjin Medical University General Hospital
I alt 15076 resultater
-
Tianjin Third Central HospitalBGI, ChinaRekrutteringHepatocellulært karcinomKina
-
Lili JiaRekrutteringGenerel anæstetika, Emergence AgitationKina
-
Tianjin Medical UniversityAstraZenecaUkendtStabil koronar sygdom | Type 2 Diabetes Mellitus;Kina
-
Wei GaoIkke rekrutterer endnuLevertransplantation; Komplikationer | Immunsuppression | ImmuntoleranceKina
-
Tianjin Central Hospital of Gynecology ObstetricsRekrutteringKromosomafvigelserKina
-
Beijing Anzhen HospitalGeneral Hospital of Ningxia Medical University; Tianjin First Central Hospital og andre samarbejdspartnereUkendt
-
Shanghai Zhongshan HospitalWest China Hospital; Tianjin Medical University General Hospital; The Affiliated...Aktiv, ikke rekrutterendeIntra-abdominal infektion | Postoperative lungekomplikationerKina
-
Shanghai Operation Robot Co., Ltd.Changhai Hospital; Xuanwu Hospital, Beijing; Tianjin Medical University General...Ikke rekrutterer endnu
-
Tianjin Medical University Cancer Institute and...Ikke rekrutterer endnuMavekræft | Gastrisk Adenocarcinom | Gastroøsofageal Junction AdenocarcinomKina
-
Tianjin Medical University Cancer Institute and...Rekruttering
-
Tianjin Medical University Cancer Institute and...RekrutteringGenerel anæstesi Gastrointestinal kræftkirurgiKina
-
Tianjin Medical University Cancer Institute and...RekrutteringHepatocellulært karcinom | Hepatocellulært karcinom Ikke-operabeltKina
-
Tianjin Medical University Cancer Institute and...Ikke rekrutterer endnuIntrahepatisk cholangiocarcinomKina
-
Tianjin Medical University Cancer Institute and...Ikke rekrutterer endnuAvanceret/metastatisk tyktarmskræftKina
-
Tianjin Medical University Cancer Institute and...RekrutteringBilledkvalitet og konturnøjagtighed af tumoren i strålebehandlingKina
-
Tianjin Medical University Cancer Institute and...RekrutteringMavekræft | No.12a LymfeknudedissektionKina
-
Tianjin Medical University Cancer Institute and...RekrutteringMavekræft | Prædiktiv kræftmodel | Hepatisk metastaseKina
-
Tianjin Medical University Cancer Institute and...Rekruttering
-
Tianjin Medical University Cancer Institute and...RekrutteringBugspytkirtelkræft | Prædiktiv kræftmodelKina
-
Tianjin Medical University Cancer Institute and...Ikke rekrutterer endnuPDAC - Pancreatic Ductal Adenocarcinoma
-
Tianjin Medical University Cancer Institute and...Rekruttering
-
Tianjin Medical University Cancer Institute and...Ikke rekrutterer endnuIkke-småcellet lungekræft tilbagevendende
-
Tianjin Medical University Cancer Institute and...RekrutteringAvanceret galdevejskræftKina
-
Tianjin Medical University Cancer Institute and...Ikke rekrutterer endnu
-
Tianjin Medical University Cancer Institute and...Ikke rekrutterer endnuNSCLC | EGFR-aktiverende mutation | Anlotinib | TP53 | Aumolertinib
-
Tianjin Medical University Cancer Institute and...Rekruttering
-
Tianjin Medical University Cancer Institute and...RekrutteringIntrahepatisk cholangiocarcinom | Durvalumab | GemcisKina
-
Tianjin Medical University Cancer Institute and...Ikke rekrutterer endnu
-
Tianjin Medical University Cancer Institute and...Rekruttering
-
Tianjin Medical University Cancer Institute and...Rekruttering
-
Tianjin Medical University Cancer Institute and...Ikke rekrutterer endnuIntrahepatisk cholangiocarcinomKina
-
Tianjin Medical University Cancer Institute and...RekrutteringPlanocellulært karcinom i hoved og hals | Neoadjuverende kemoterapiKina
-
Tianjin Medical University Cancer Institute and...Rekruttering
-
Tianjin Medical University Cancer Institute and...RekrutteringUoprettelig | Esophageal pladecellecarcinom af AJCC V8 StageKina
-
Tianjin Medical University Cancer Institute and...RekrutteringKemoterapi-induceret kvalme og opkastningKina
-
Tianjin Medical University Cancer Institute and...RekrutteringKarcinom, ikke-småcellet lunge | EGF-R positiv ikke-småcellet lungekræft | Bevacizumab | TyrosinkinasehæmmerKina
-
Tianjin Medical University Cancer Institute and...RekrutteringFørstelinjes behandling | Avanceret gastrisk karcinomKina
-
Tianjin Medical University Cancer Institute and...RekrutteringAvanceret HER2 negativ brystkarcinom | HRD+brystkræftKina
-
Tianjin Medical University Cancer Institute and...RekrutteringMSI-H Advanced Colorectal CancerKina
-
Tianjin Medical University Cancer Institute and...RekrutteringHepatocellulært karcinomKina
-
Tianjin Medical University Cancer Institute and...Rekruttering
-
Tianjin Medical University Cancer Institute and...RekrutteringTyktarmskræft | Immunterapi | MSI-H | Adjuverende terapiKina
-
Tianjin Medical University Cancer Institute and...RekrutteringLokalt avanceret livmoderhalskræftKina
-
Tianjin Medical University Cancer Institute and...Rekruttering
-
Tianjin Medical University Cancer Institute and...RekrutteringPembrolizumab | Neoadjuverende kemoterapi | Adenocarcinom af Esophagogastric JunctionKina
-
Tianjin Medical University Cancer Institute and...RekrutteringMavekræft | Peristaltisk retning | Roux-en-Y Gastrointestinal anastomoseKina
-
Tianjin Medical University Cancer Institute and...RekrutteringSintilimab, Cetuximab, Regorafenib, Combine, mCRCKina
-
Tianjin Medical University Cancer Institute and...RekrutteringResektabelt hepatocellulært karcinomKina
-
Tianjin Medical University Cancer Institute and...RekrutteringLungeneoplasmer | LymfeknudeudskæringKina
-
Tianjin Medical University Cancer Institute and...RekrutteringBrystkræft | Fulvestrant | PalbociclibKina